Nicotine Reinforcement and Smoking-Cue Reactivity: Association With Genetic Polymorphisms
NCT ID: NCT02921282
Last Updated: 2024-03-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2016-08-31
2019-11-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Unraveling the Genetic Basis of Nicotine Addiction for Novel Therapeutic Strategies
NCT06471387
A Dietary Supplement for Early Cigarette Withdrawal
NCT02042521
Electronic Cigarettes and Reactivity to Smoking Cues
NCT01782599
A Study in a Human Laboratory Model of Smoking Behavior
NCT02641028
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
NCT03362099
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Genotype dopamine
Genotyping will be conducted at the conclusion of the study
Genotype dopamine
Laboratory investigations of nicotine reinforcement
Genotype cannabinoids
Laboratory investigations of nicotine reinforcement
Genotype cannabinoids
Genotyping will be conducted at the conclusion of the study
Genotype dopamine
Laboratory investigations of nicotine reinforcement
Genotype cannabinoids
Laboratory investigations of nicotine reinforcement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Genotype dopamine
Laboratory investigations of nicotine reinforcement
Genotype cannabinoids
Laboratory investigations of nicotine reinforcement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. smoking at least 10 cigarettes per day for at least 1 year
3. positive urinary cotinine
4. medically and psychologically healthy as determined by screening criteria
Exclusion Criteria
2. treatment for tobacco dependence in the past 3 months
3. use of nicotine replacement products, bupropion, or varenicline in the past 3 months
4. consumption of more than 15 alcoholic drinks per week during the past month
5. use of any illicit drug more than twice per week during the past month
6. current use of any medication that would interfere with the protocol in the opinion of PI
7. under the influence of a drug or alcohol at any session
8. pregnant, nursing, or become pregnant during the study
19 Years
64 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Addiction and Mental Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernard Le Foll
Scientist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernard Le Foll, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CAMH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre for Addiction and Mental Health
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
134-2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.